Fulcrum Therapeutics (FULC) Change in Account Payables (2018 - 2026)
Fulcrum Therapeutics' (FULC) quarterly Change in Account Payables came in at $858000.0 in Q1 2026, up 150.15% year-on-year from $343000.0 in Q1 2025, and up 177.65% on a QoQ basis from -$1.1 million in Q4 2025.
Fulcrum Therapeutics (FULC) Change in Account Payables (2018 - 2026) Analysis & Trends
Fulcrum Therapeutics (FULC) has 9 years of Change in Account Payables data on file, last reported at $858000.0 in Q1 2026.
- On a quarterly basis, Change in Account Payables rose 150.15% year-over-year to $858000.0 in Q1 2026; TTM through Mar 2026 was $943000.0, a 140.13% increase from a year earlier, with the FY2025 full-year figure at $428000.0, up 126.87% from the prior year.
- Change in Account Payables for Q1 2026 stood at $858000.0, up from -$1.1 million in the prior quarter.
- Over the last five years, Change in Account Payables for FULC reached as high as $1.1 million in Q1 2024 and fell as low as -$2.7 million in Q4 2024.
- Historically, Change in Account Payables has averaged -$137411.8 across 5 years, with a median of $163000.0 in 2023.
- On a YoY basis, Change in Account Payables climbed as much as 1150.0% in 2024 and fell as far as 279.75% in 2024.
- Year by year, Change in Account Payables stood at $903000.0 in 2022, then sank by 190.48% to -$817000.0 in 2023, then slumped by 230.11% to -$2.7 million in 2024, then jumped by 59.03% to -$1.1 million in 2025, then surged by 177.65% to $858000.0 in 2026.
- Per Business Quant data, the three most recent Change in Account Payables figures were $858000.0 in Q1 2026, -$1.1 million in Q4 2025, and $946000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -42.19 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.52 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 35.60 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.86 Mn |
| 10 | Fulcrum Therapeutics | 286.57 Mn | 286.57 Mn | - | 858,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 858,000.00 |
| Mar 31, 2026 | 858,000.00 |
| Dec 31, 2025 | -1.11 Mn |
| Dec 31, 2025 | -1.11 Mn |
| Sep 30, 2025 | 946,000.00 |
| Sep 30, 2025 | 946,000.00 |
| Jun 30, 2025 | 244,000.00 |
| Jun 30, 2025 | 244,000.00 |
| Mar 31, 2025 | 343,000.00 |
| Mar 31, 2025 | 343,000.00 |
| Dec 31, 2024 | -2.70 Mn |
| Dec 31, 2024 | -2.70 Mn |
| Sep 30, 2024 | 297,000.00 |
| Sep 30, 2024 | 297,000.00 |
| Jun 30, 2024 | -293,000.00 |
| Jun 30, 2024 | -293,000.00 |
| Mar 31, 2024 | 1.10 Mn |
| Mar 31, 2024 | 1.10 Mn |
| Dec 31, 2023 | -817,000.00 |
| Dec 31, 2023 | -817,000.00 |